aluates Reports

$ 0.0

Automative

Global DPT Series Vaccine Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-7H17870

BUY CHAPTERS

Global DPT Series Vaccine Market Research Report 2024

Code: QYRE-Auto-7H17870

Report

July 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vendors

CNBG

Panacea Biotec

GSK

Sanofi

Sanofi S A

AJ Vaccines

Hualan Biological Vaccine

Biokangtai

Walvax Biotechnology

CanSino Biologics

Chongqing Zhifei Biological Products

DPT Series Vaccine Market

The global DPT Series Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for DPT Series Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for DPT Series Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of DPT Series Vaccine include Sanofi, GSK, AJ Vaccines, Panacea Biotec, CNBG, Hualan Biological Vaccine, BioKangtai, Walvax Biotechnology, CanSino Biologics, Chongqing Zhifei Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DPT Series Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Series Vaccine.

The DPT Series Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global DPT Series Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the DPT Series Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DPT Series Vaccine Market Report

Report Metric	Details
Report Name	DPT Series Vaccine Market
Segment by Type	Absorbed Diphtheria-Tetanus Combined Vaccine Absorbed Tetanus Vaccine Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine DTP-Hib Quadruple Vaccine DTP-IPV-Hib Pentavalent Vaccine
Segment by Application	Adults Children
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, GSK, AJ Vaccines, Panacea Biotec, CNBG, Hualan Biological Vaccine, BioKangtai, Walvax Biotechnology, CanSino Biologics, Chongqing Zhifei Biological Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPT Series Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPT Series Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the DPT Series Vaccine Market report?

Ans: The main players in the DPT Series Vaccine Market are Sanofi, GSK, AJ Vaccines, Panacea Biotec, CNBG, Hualan Biological Vaccine, BioKangtai, Walvax Biotechnology, CanSino Biologics, Chongqing Zhifei Biological Products

What are the Application segmentation covered in the DPT Series Vaccine Market report?

Ans: The Applications covered in the DPT Series Vaccine Market report are Adults, Children

What are the Type segmentation covered in the DPT Series Vaccine Market report?

Ans: The Types covered in the DPT Series Vaccine Market report are Absorbed Diphtheria-Tetanus Combined Vaccine, Absorbed Tetanus Vaccine, Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine, DTP-Hib Quadruple Vaccine, DTP-IPV-Hib Pentavalent Vaccine

Recommended Reports

Human Vaccines Markets

Vaccine Devices & Delivery

Adjuvants & Combination Vaccines

1 DPT Series Vaccine Market Overview

1.1 Product Definition

1.2 DPT Series Vaccine by Type

1.2.1 Global DPT Series Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Absorbed Diphtheria-Tetanus Combined Vaccine

1.2.3 Absorbed Tetanus Vaccine

1.2.4 Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine

1.2.5 DTP-Hib Quadruple Vaccine

1.2.6 DTP-IPV-Hib Pentavalent Vaccine

1.3 DPT Series Vaccine by Application

1.3.1 Global DPT Series Vaccine Market Value by Application (2024-2030)

1.3.2 Adults

1.3.3 Children

1.4 Global DPT Series Vaccine Market Size Estimates and Forecasts

1.4.1 Global DPT Series Vaccine Revenue 2019-2030

1.4.2 Global DPT Series Vaccine Sales 2019-2030

1.4.3 Global DPT Series Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 DPT Series Vaccine Market Competition by Manufacturers

2.1 Global DPT Series Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global DPT Series Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global DPT Series Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of DPT Series Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of DPT Series Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of DPT Series Vaccine, Product Type & Application

2.7 Global Key Manufacturers of DPT Series Vaccine, Date of Enter into This Industry

2.8 Global DPT Series Vaccine Market Competitive Situation and Trends

2.8.1 Global DPT Series Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest DPT Series Vaccine Players Market Share by Revenue

2.8.3 Global DPT Series Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global DPT Series Vaccine Market Scenario by Region

3.1 Global DPT Series Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global DPT Series Vaccine Sales by Region: 2019-2030

3.2.1 Global DPT Series Vaccine Sales by Region: 2019-2024

3.2.2 Global DPT Series Vaccine Sales by Region: 2025-2030

3.3 Global DPT Series Vaccine Revenue by Region: 2019-2030

3.3.1 Global DPT Series Vaccine Revenue by Region: 2019-2024

3.3.2 Global DPT Series Vaccine Revenue by Region: 2025-2030

3.4 North America DPT Series Vaccine Market Facts & Figures by Country

3.4.1 North America DPT Series Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America DPT Series Vaccine Sales by Country (2019-2030)

3.4.3 North America DPT Series Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe DPT Series Vaccine Market Facts & Figures by Country

3.5.1 Europe DPT Series Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe DPT Series Vaccine Sales by Country (2019-2030)

3.5.3 Europe DPT Series Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific DPT Series Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific DPT Series Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific DPT Series Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific DPT Series Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America DPT Series Vaccine Market Facts & Figures by Country

3.7.1 Latin America DPT Series Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America DPT Series Vaccine Sales by Country (2019-2030)

3.7.3 Latin America DPT Series Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa DPT Series Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa DPT Series Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa DPT Series Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa DPT Series Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global DPT Series Vaccine Sales by Type (2019-2030)

4.1.1 Global DPT Series Vaccine Sales by Type (2019-2024)

4.1.2 Global DPT Series Vaccine Sales by Type (2025-2030)

4.1.3 Global DPT Series Vaccine Sales Market Share by Type (2019-2030)

4.2 Global DPT Series Vaccine Revenue by Type (2019-2030)

4.2.1 Global DPT Series Vaccine Revenue by Type (2019-2024)

4.2.2 Global DPT Series Vaccine Revenue by Type (2025-2030)

4.2.3 Global DPT Series Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global DPT Series Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global DPT Series Vaccine Sales by Application (2019-2030)

5.1.1 Global DPT Series Vaccine Sales by Application (2019-2024)

5.1.2 Global DPT Series Vaccine Sales by Application (2025-2030)

5.1.3 Global DPT Series Vaccine Sales Market Share by Application (2019-2030)

5.2 Global DPT Series Vaccine Revenue by Application (2019-2030)

5.2.1 Global DPT Series Vaccine Revenue by Application (2019-2024)

5.2.2 Global DPT Series Vaccine Revenue by Application (2025-2030)

5.2.3 Global DPT Series Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global DPT Series Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi DPT Series Vaccine Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK DPT Series Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 AJ Vaccines

6.3.1 AJ Vaccines Company Information

6.3.2 AJ Vaccines Description and Business Overview

6.3.3 AJ Vaccines DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AJ Vaccines DPT Series Vaccine Product Portfolio

6.3.5 AJ Vaccines Recent Developments/Updates

6.4 Panacea Biotec

6.4.1 Panacea Biotec Company Information

6.4.2 Panacea Biotec Description and Business Overview

6.4.3 Panacea Biotec DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Panacea Biotec DPT Series Vaccine Product Portfolio

6.4.5 Panacea Biotec Recent Developments/Updates

6.5 CNBG

6.5.1 CNBG Company Information

6.5.2 CNBG Description and Business Overview

6.5.3 CNBG DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 CNBG DPT Series Vaccine Product Portfolio

6.5.5 CNBG Recent Developments/Updates

6.6 Hualan Biological Vaccine

6.6.1 Hualan Biological Vaccine Company Information

6.6.2 Hualan Biological Vaccine Description and Business Overview

6.6.3 Hualan Biological Vaccine DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hualan Biological Vaccine DPT Series Vaccine Product Portfolio

6.6.5 Hualan Biological Vaccine Recent Developments/Updates

6.7 BioKangtai

6.7.1 BioKangtai Company Information

6.7.2 BioKangtai Description and Business Overview

6.7.3 BioKangtai DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.7.4 BioKangtai DPT Series Vaccine Product Portfolio

6.7.5 BioKangtai Recent Developments/Updates

6.8 Walvax Biotechnology

6.8.1 Walvax Biotechnology Company Information

6.8.2 Walvax Biotechnology Description and Business Overview

6.8.3 Walvax Biotechnology DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Walvax Biotechnology DPT Series Vaccine Product Portfolio

6.8.5 Walvax Biotechnology Recent Developments/Updates

6.9 CanSino Biologics

6.9.1 CanSino Biologics Company Information

6.9.2 CanSino Biologics Description and Business Overview

6.9.3 CanSino Biologics DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 CanSino Biologics DPT Series Vaccine Product Portfolio

6.9.5 CanSino Biologics Recent Developments/Updates

6.10 Chongqing Zhifei Biological Products

6.10.1 Chongqing Zhifei Biological Products Company Information

6.10.2 Chongqing Zhifei Biological Products Description and Business Overview

6.10.3 Chongqing Zhifei Biological Products DPT Series Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolio

6.10.5 Chongqing Zhifei Biological Products Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 DPT Series Vaccine Industry Chain Analysis

7.2 DPT Series Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 DPT Series Vaccine Production Mode & Process

7.4 DPT Series Vaccine Sales and Marketing

7.4.1 DPT Series Vaccine Sales Channels

7.4.2 DPT Series Vaccine Distributors

7.5 DPT Series Vaccine Customers

8 DPT Series Vaccine Market Dynamics

8.1 DPT Series Vaccine Industry Trends

8.2 DPT Series Vaccine Market Drivers

8.3 DPT Series Vaccine Market Challenges

8.4 DPT Series Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vendors

CNBG

Panacea Biotec

GSK

Sanofi

Sanofi S A

AJ Vaccines

Hualan Biological Vaccine

Biokangtai

Walvax Biotechnology

CanSino Biologics

Chongqing Zhifei Biological Products

List of Tables

Table 1. Global DPT Series Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global DPT Series Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global DPT Series Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global DPT Series Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global DPT Series Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global DPT Series Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global DPT Series Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market DPT Series Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of DPT Series Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of DPT Series Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of DPT Series Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of DPT Series Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global DPT Series Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPT Series Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global DPT Series Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global DPT Series Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global DPT Series Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global DPT Series Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global DPT Series Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global DPT Series Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global DPT Series Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global DPT Series Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global DPT Series Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America DPT Series Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America DPT Series Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America DPT Series Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America DPT Series Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America DPT Series Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe DPT Series Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe DPT Series Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe DPT Series Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe DPT Series Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe DPT Series Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific DPT Series Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific DPT Series Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific DPT Series Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific DPT Series Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific DPT Series Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America DPT Series Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America DPT Series Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America DPT Series Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America DPT Series Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America DPT Series Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa DPT Series Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa DPT Series Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa DPT Series Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa DPT Series Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa DPT Series Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global DPT Series Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global DPT Series Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global DPT Series Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global DPT Series Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global DPT Series Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global DPT Series Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global DPT Series Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global DPT Series Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global DPT Series Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global DPT Series Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global DPT Series Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global DPT Series Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global DPT Series Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global DPT Series Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global DPT Series Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global DPT Series Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global DPT Series Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global DPT Series Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global DPT Series Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global DPT Series Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Sanofi DPT Series Vaccine Product

Table 74. Sanofi Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GSK DPT Series Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. AJ Vaccines Company Information

Table 81. AJ Vaccines Description and Business Overview

Table 82. AJ Vaccines DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AJ Vaccines DPT Series Vaccine Product

Table 84. AJ Vaccines Recent Developments/Updates

Table 85. Panacea Biotec Company Information

Table 86. Panacea Biotec Description and Business Overview

Table 87. Panacea Biotec DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Panacea Biotec DPT Series Vaccine Product

Table 89. Panacea Biotec Recent Developments/Updates

Table 90. CNBG Company Information

Table 91. CNBG Description and Business Overview

Table 92. CNBG DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. CNBG DPT Series Vaccine Product

Table 94. CNBG Recent Developments/Updates

Table 95. Hualan Biological Vaccine Company Information

Table 96. Hualan Biological Vaccine Description and Business Overview

Table 97. Hualan Biological Vaccine DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hualan Biological Vaccine DPT Series Vaccine Product

Table 99. Hualan Biological Vaccine Recent Developments/Updates

Table 100. BioKangtai Company Information

Table 101. BioKangtai Description and Business Overview

Table 102. BioKangtai DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. BioKangtai DPT Series Vaccine Product

Table 104. BioKangtai Recent Developments/Updates

Table 105. Walvax Biotechnology Company Information

Table 106. Walvax Biotechnology Description and Business Overview

Table 107. Walvax Biotechnology DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Walvax Biotechnology DPT Series Vaccine Product

Table 109. Walvax Biotechnology Recent Developments/Updates

Table 110. CanSino Biologics Company Information

Table 111. CanSino Biologics Description and Business Overview

Table 112. CanSino Biologics DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. CanSino Biologics DPT Series Vaccine Product

Table 114. CanSino Biologics Recent Developments/Updates

Table 115. Chongqing Zhifei Biological Products Company Information

Table 116. Chongqing Zhifei Biological Products Description and Business Overview

Table 117. Chongqing Zhifei Biological Products DPT Series Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Chongqing Zhifei Biological Products DPT Series Vaccine Product

Table 119. Chongqing Zhifei Biological Products Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. DPT Series Vaccine Distributors List

Table 123. DPT Series Vaccine Customers List

Table 124. DPT Series Vaccine Market Trends

Table 125. DPT Series Vaccine Market Drivers

Table 126. DPT Series Vaccine Market Challenges

Table 127. DPT Series Vaccine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of DPT Series Vaccine

Figure 2. Global DPT Series Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global DPT Series Vaccine Market Share by Type: 2023 & 2030

Figure 4. Absorbed Diphtheria-Tetanus Combined Vaccine Product Picture

Figure 5. Absorbed Tetanus Vaccine Product Picture

Figure 6. Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Product Picture

Figure 7. DTP-Hib Quadruple Vaccine Product Picture

Figure 8. DTP-IPV-Hib Pentavalent Vaccine Product Picture

Figure 9. Global DPT Series Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 10. Global DPT Series Vaccine Market Share by Application: 2023 & 2030

Figure 11. Adults

Figure 12. Children

Figure 13. Global DPT Series Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global DPT Series Vaccine Market Size (2019-2030) & (US$ Million)

Figure 15. Global DPT Series Vaccine Sales (2019-2030) & (K Units)

Figure 16. Global DPT Series Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 17. DPT Series Vaccine Report Years Considered

Figure 18. DPT Series Vaccine Sales Share by Manufacturers in 2023

Figure 19. Global DPT Series Vaccine Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest DPT Series Vaccine Players: Market Share by Revenue in DPT Series Vaccine in 2023

Figure 21. DPT Series Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global DPT Series Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America DPT Series Vaccine Sales Market Share by Country (2019-2030)

Figure 24. North America DPT Series Vaccine Revenue Market Share by Country (2019-2030)

Figure 25. United States DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe DPT Series Vaccine Sales Market Share by Country (2019-2030)

Figure 28. Europe DPT Series Vaccine Revenue Market Share by Country (2019-2030)

Figure 29. Germany DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific DPT Series Vaccine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific DPT Series Vaccine Revenue Market Share by Region (2019-2030)

Figure 36. China DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America DPT Series Vaccine Sales Market Share by Country (2019-2030)

Figure 44. Mexico DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa DPT Series Vaccine Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa DPT Series Vaccine Revenue Market Share by Country (2019-2030)

Figure 50. Turkey DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE DPT Series Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of DPT Series Vaccine by Type (2019-2030)

Figure 54. Global Revenue Market Share of DPT Series Vaccine by Type (2019-2030)

Figure 55. Global DPT Series Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of DPT Series Vaccine by Application (2019-2030)

Figure 57. Global Revenue Market Share of DPT Series Vaccine by Application (2019-2030)

Figure 58. Global DPT Series Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 59. DPT Series Vaccine Value Chain

Figure 60. DPT Series Vaccine Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Component DTP Vaccine Market Research Report 2024

Global TD Vaccine Market Research Report 2025

Global Seasonal Vaccines Market Research Report 2024

Global Multiple Vaccine Market Research Report 2024

Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025

Global Vaccination Device Market Research Report 2024

Global DT Based Combined Vaccines Market Research Report 2024

Global Vaccines for the Elderly Market Research Report 2024

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Consumption Type Vaccine Market Research Report 2024

Global Adult Vaccines Market Research Report 2024

Global DPT Vaccines Market Research Report 2025

Global Acellular DTP Vaccine Market Research Report 2024

Global Tick borne Encephalitis Vaccine Market Research Report 2024

DTaP Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adsorption of DTP Combination Vaccine Market Research Report 2025

Global DPT Vaccination Market Research Report 2025

Global Tetanus Toxoid Vaccine Market Research Report 2024

Global Combination Vaccine and Multivalent Vaccine Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions